SL Science H1 2026 Net Loss Widens 35% to $2.16 Million

• SL Science's net loss widened 35% year over year to $2.16 million for the six months ended June 30, 2026.
• Net revenue rose 23% to $1.39 million, driven by higher shipment volumes through its wholesale distribution model.
• Gross margin improved to 40.2% on favorable supplier procurement terms.
• Research and development expenses jumped 72% to $1.23 million, driven by higher staff salaries and milestone payments.
• Cash and cash equivalents rose to $8.31 million; the company secured $7.8 million in PIPE financing alongside its Nasdaq listing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SL Science Holding Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-118805), on October 26, 2026, and is solely responsible for the information contained therein.